Published in Cell Death Differ on March 22, 2013
A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1. Cell (2013) 1.84
Depletion of RIPK3 or MLKL blocks TNF-driven necroptosis and switches towards a delayed RIPK1 kinase-dependent apoptosis. Cell Death Dis (2014) 1.33
PINK1 triggers autocatalytic activation of Parkin to specify cell fate decisions. Curr Biol (2014) 1.02
Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis. Autophagy (2014) 0.96
PINK1-mediated phosphorylation of Miro inhibits synaptic growth and protects dopaminergic neurons in Drosophila. Sci Rep (2014) 0.86
Beyond mitophagy: cytosolic PINK1 as a messenger of mitochondrial health. Antioxid Redox Signal (2015) 0.82
Cdk2 phosphorylation of Bcl-xL after stress converts it to a pro-apoptotic protein mimicking Bax/Bak. Cell Death Discov (2016) 0.79
Deconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purpose. Oncotarget (2015) 0.78
NRF2 Regulates PINK1 Expression under Oxidative Stress Conditions. PLoS One (2015) 0.78
Phospho-Bcl-xL(Ser62) influences spindle assembly and chromosome segregation during mitosis. Cell Cycle (2014) 0.78
BECLIN 1-VPS34 COMPLEX ARCHITECTURE: UNDERSTANDING THE NUTS AND BOLTS OF THERAPEUTIC TARGETS. Front Biol (Beijing) (2015) 0.77
PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology? J Parkinsons Dis (2016) 0.76
Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network. Brain Res (2015) 0.76
Lugrandoside attenuates LPS-induced acute respiratory distress syndrome by anti-inflammation and anti-apoptosis in mice. Am J Transl Res (2016) 0.75
Pan-Cancer Analysis Links PARK2 to BCL-XL-Dependent Control of Apoptosis. Neoplasia (2016) 0.75
JNK1 Inhibition Attenuates Hypoxia-Induced Autophagy and Sensitizes to Chemotherapy. Mol Cancer Res (2016) 0.75
Involvement of inhibitory PAS domain protein in neuronal cell death in Parkinson's disease. Cell Death Discov (2015) 0.75
PINK1 and BECN1 relocalize at mitochondria-associated membranes during mitophagy and promote ER-mitochondria tethering and autophagosome formation. Autophagy (2017) 0.75
PINK1-dependent phosphorylation of PINK1 and Parkin is essential for mitochondrial quality control. Cell Death Dis (2016) 0.75
In Vitro Comparison of the Activity Requirements and Substrate Specificity of Human and Triboleum castaneum PINK1 Orthologues. PLoS One (2016) 0.75
Cytoprotection against Hypoxic and/or MPP⁺ Injury: Effect of δ-Opioid Receptor Activation on Caspase 3. Int J Mol Sci (2016) 0.75
Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science (2004) 15.91
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol (2010) 12.26
PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol (2010) 11.85
Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J (2007) 11.72
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A (2009) 8.25
PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell (2011) 5.98
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1. Nat Cell Biol (2007) 4.60
Mitochondria in the aetiology and pathogenesis of Parkinson's disease. Lancet Neurol (2008) 4.58
Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A (2008) 4.50
Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism. Mol Cell Biol (2008) 4.47
Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy (2008) 4.42
The Beclin 1 interactome. Curr Opin Cell Biol (2010) 4.13
PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol (2007) 3.86
Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet (2005) 3.76
Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol (2010) 3.68
Bcl-x(L) retrotranslocates Bax from the mitochondria into the cytosol. Cell (2011) 3.23
PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell (2009) 3.17
Modulation of cell death by Bcl-XL through caspase interaction. Proc Natl Acad Sci U S A (1998) 2.42
PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS One (2008) 2.33
PINK1 cleavage at position A103 by the mitochondrial protease PARL. Hum Mol Genet (2010) 2.30
Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene (2001) 2.25
Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J (2010) 2.13
Are Parkinson disease patients protected from some but not all cancers? Neurology (2007) 2.12
Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep (2012) 2.08
BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc Natl Acad Sci U S A (2000) 2.06
The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ (2010) 1.63
Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. J Neurochem (2009) 1.52
Identification of the major phosphorylation site in Bcl-xL induced by microtubule inhibitors and analysis of its functional significance. J Biol Chem (2008) 1.46
A pivotal role for PINK1 and autophagy in mitochondrial quality control: implications for Parkinson disease. Hum Mol Genet (2010) 1.41
N-terminally cleaved Bcl-xL mediates ischemia-induced neuronal death. Nat Neurosci (2012) 1.36
Dynamics of expression of apoptosis-regulatory proteins Bid, Bcl-2, Bcl-X, Bax and Bak during development of murine nervous system. Cell Death Differ (2002) 1.23
Parkinson's disease: a genetic perspective. FEBS J (2008) 1.16
Bcl-xL is phosphorylated in malignant cells following microtubule disruption. Cancer Res (1998) 1.15
Update on Parkinson disease. Ann Intern Med (2003) 1.06
Unmasking of phosphorylation-sensitive epitopes on p53 and Mdm2 by a simple Western-phosphatase procedure. Oncogene (2000) 1.04
Effect of caspase cleavage-site phosphorylation on proteolysis. Biochem J (2003) 1.01
Alternative macroautophagic pathways. Int J Cell Biol (2012) 1.00
PINK1 displays tissue-specific subcellular location and regulates apoptosis and cell growth in breast cancer cells. Hum Pathol (2010) 0.90
Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis. Mol Pharmacol (2002) 0.89
Synchronised phosphorylation of BNIP3, Bcl-2 and Bcl-xL in response to microtubule-active drugs is JNK-independent and requires a mitotic kinase. Biochem Pharmacol (2010) 0.86
Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1. Oncol Rep (2011) 0.82
Late onset sporadic Parkinson's disease caused by PINK1 mutations: clinical and functional study. Mov Disord (2008) 0.80
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature (2006) 7.69
Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature (1998) 5.30
Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. Mol Cell (2000) 2.02
A new method for autozygosity mapping using single nucleotide polymorphisms (SNPs) and EXCLUDEAR. J Med Genet (2004) 2.02
The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death Differ (2010) 1.63
Neurophysiological classification and sensitivity in 500 carpal tunnel syndrome hands. Acta Neurol Scand (1997) 1.57
p53 activity and chemotherapy. Nat Med (1996) 1.53
Constitutive degradation of PML/RARalpha through the proteasome pathway mediates retinoic acid resistance. Blood (1999) 1.50
NPHP1 gene deletion is a rare cause of Joubert syndrome related disorders. J Med Genet (2005) 1.47
Caspases mediate retinoic acid-induced degradation of the acute promyelocytic leukemia PML/RARalpha fusion protein. Blood (1998) 1.45
A locus for autosomal dominant keratoconus maps to human chromosome 3p14-q13. J Med Genet (2004) 1.36
Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. Cancer Res (2001) 1.33
Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains. EMBO J (1996) 1.27
Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol (1998) 1.25
Diffusion tensor imaging in Joubert syndrome. AJNR Am J Neuroradiol (2007) 1.25
Mitochondrial factors with dual roles in death and survival. Oncogene (2006) 1.23
Oligomerization of ETO is obligatory for corepressor interaction. Mol Cell Biol (2001) 1.22
Suprascapular nerve entrapment. Neurophysiological localization in 6 cases. Acta Orthop Scand (1996) 1.13
A family study on primary blepharospasm. J Neurol Neurosurg Psychiatry (2006) 1.13
The A-Myb transcription factor is a marker of centroblasts in vivo. J Immunol (1998) 1.10
KTF-1, a transcriptional activator of Xenopus embryonic keratin expression. Development (1990) 1.09
Choroidal neovascularisation as an unusual ophthalmic manifestation of cat-scratch disease in an 8-year-old girl. Int Ophthalmol (2015) 1.08
The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Neurology (2005) 1.07
Nephronophthisis type 1 deletion syndrome with neurological symptoms: prevalence and significance of the association. Kidney Int (2006) 1.06
Development of a non invasive NGF-based therapy for Alzheimer's disease. Curr Alzheimer Res (2009) 1.04
Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations. Oncogene (1997) 1.03
RPGRIP1L mutations are mainly associated with the cerebello-renal phenotype of Joubert syndrome-related disorders. Clin Genet (2008) 1.03
PML/RAR alpha fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype. Blood (2000) 1.02
A Yorkshire family with adult-onset cranio-cervical primary torsion dystonia. Mov Disord (2000) 0.99
Acute myocardial infarction with normal coronary artery: a case report and review of literature. Am J Med Sci (1997) 0.99
A useful electrophysiologic parameter for diagnosis of carpal tunnel syndrome. Muscle Nerve (1996) 0.97
Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosum. Neurology (2004) 0.95
Ophthalmological findings in Joubert syndrome. Eye (Lond) (2009) 0.95
Validity study of the short portable mental status questionnaire for the elderly. J Am Geriatr Soc (1979) 0.95
Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A. J Neurol Neurosurg Psychiatry (2003) 0.95
Formation of PML/RAR alpha high molecular weight nuclear complexes through the PML coiled-coil region is essential for the PML/RAR alpha-mediated retinoic acid response. Oncogene (1999) 0.95
Common themes in the pathogenesis of acute myeloid leukemia. Oncogene (2001) 0.95
Phenotypic characterisation of autosomal recessive PARK6-linked parkinsonism in three unrelated Italian families. Mov Disord (2001) 0.95
Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families. Neurology (2003) 0.94
Surgical prognosis in carpal tunnel syndrome: usefulness of a preoperative neurophysiological assessment. Acta Neurol Scand (1996) 0.94
Receptors, signal transduction, and spectrum of action of monocyte chemotactic protein-1 and related chemokines. J Leukoc Biol (1995) 0.94
The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease. Neurology (2005) 0.93
A new family with paroxysmal exercise induced dystonia and migraine: a clinical and genetic study. J Neurol Neurosurg Psychiatry (2000) 0.92
Low limb and allograft rescue with iliofemoral graft for external iliac artery dissection: case report. Transplant Proc (2010) 0.92
Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network. Ann Oncol (2011) 0.91
Autosomal dominant hereditary benign telangiectasia maps to the CMC1 locus for capillary malformation on chromosome 5q14. J Med Genet (2003) 0.91
Normal cognitive functions in joubert syndrome. Neuropediatrics (2010) 0.91
Primary torsion dystonia: the search for genes is not over. J Neurol Neurosurg Psychiatry (1999) 0.90
Ca2+ influx and activation of a cation current are coupled to intracellular Ca2+ release in peptidergic neurons of Aplysia californica. J Physiol (1996) 0.90
Expression profiling in peripheral blood reveals signature for penetrance in DYT1 dystonia. Neurobiol Dis (2010) 0.88
Increased expression of the negative growth factor, galactoside-binding protein, gene in transformed thyroid cells and in human thyroid carcinomas. Oncogene (1992) 0.87
Inhibition of monocyte chemotaxis to C-C chemokines by antisense oligonucleotide for cytosolic phospholipase A2. J Biol Chem (1996) 0.87
Infantile and childhood onset PLA2G6-associated neurodegeneration in a large North African cohort. Eur J Neurol (2014) 0.87
Multipotential neural precursors transplanted into the metachromatic leukodystrophy brain fail to generate oligodendrocytes but contribute to limit brain dysfunction. Dev Neurosci (2008) 0.86
Silencing of membrane-associated sialidase Neu3 diminishes apoptosis resistance and triggers megakaryocytic differentiation of chronic myeloid leukemic cells K562 through the increase of ganglioside GM3. Cell Death Differ (2008) 0.86
Joubert syndrome with bilateral polymicrogyria: clinical and neuropathological findings in two brothers. Am J Med Genet A (2009) 0.85
The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI. Br J Haematol (2001) 0.85
Recurrent and fatal akinetic crisis in genetic-mitochondrial parkinsonisms. Eur J Neurol (2014) 0.85
Evidence of subclinical heart muscle dysfunction in acromegaly. Chest (1975) 0.84
Complete His-Purkinje block produced by carotid sinus massage. Report of a case. Circulation (1974) 0.84
Phase I dose escalation study of gemcitabine and paclitaxel plus colony-stimulating factors in previously treated patients with advanced breast and ovarian cancer. Clin Oncol (R Coll Radiol) (2000) 0.83
Interneurons transiently express the ERG K+ channels during development of mouse spinal networks in vitro. Neuroscience (2005) 0.82
Terminal megakaryocytic differentiation of TF-1 cells is induced by phorbol esters and thrombopoietin and is blocked by expression of PML/RARalpha fusion protein. Leukemia (1998) 0.82
Impaired body movement representation in DYT1 mutation carriers. Clin Neurophysiol (2008) 0.82
DJ-1 mutations in Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 0.82
Expression of neurotransmitters and neurotrophins in neurogenic inflammation of the rat retina. Eur J Histochem (2007) 0.82
A subcellular analysis of genetic modulation of PINK1 on mitochondrial alterations, autophagy and cell death. Arch Ital Biol (2012) 0.81
Italian family with cranial cervical dystonia: clinical and genetic study. Mov Disord (1999) 0.81
Role of the dopamine D5 receptor (DRD5) as a susceptibility gene for cervical dystonia. J Neurol Neurosurg Psychiatry (2003) 0.80
The finding of vascular and urinary anomalies in the harvested kidney for transplantation. Transplant Proc (2007) 0.79
A phase II study of paclitaxel/cisplatin combination in patients with metastatic breast cancer refractory to anthracycline-based chemotherapy. Tumori (2000) 0.79
LAW ENFORCEMENT IN THE CONTROL OF TUBERCULOSIS. Am J Public Health (N Y) (1923) 0.79
Phenotype variability of dystonia in monozygotic twins. J Neurol (2000) 0.78
Brain-derived neurotrophic factor and risk for primary adult-onset cranial-cervical dystonia. Eur J Neurol (2009) 0.78
Platelet aggregability in rats with early atherosclerotic changes induced by parenterally-administered lipid emulsions. Atherosclerosis (1987) 0.77
Expansion of dendritic cells derived from human CD34+ cells in static and continuous perfusion cultures. Br J Haematol (1998) 0.77
Older kidneys donor transplantation: five years' experience without biopsy and using clinical laboratory and macroscopic anatomy evaluation. Transplant Proc (2007) 0.77
Healing of surgical incision in kidney transplantation: a single transplant center's experience. Transplant Proc (2006) 0.77
Induction of early atherosclerosis in rats using parenterally-administered lipid emulsions. Artery (1987) 0.77
Bench surgery in right kidney transplantation. Transplant Proc (2010) 0.76
Mitral regurgitation and MI mortality. Ann Intern Med (1993) 0.75
Treatment of nortriptyline's side effects in elderly patients: a double-blind study of bethanechol. Am J Psychiatry (1993) 0.75
Double-peaked potential in the neurophysiological evaluation of carpal tunnel syndrome. Muscle Nerve (1996) 0.75
"Tube-guided" implant of bioprosthetic shunt for hemodialysis. Am J Surg (2001) 0.75
Incomplete sister chromatid separation of long chromosome arms. Chromosoma (2006) 0.75
Transplantation and young surgeons in Italy. Transplant Proc (2006) 0.75
[Hand ischemia due to "steal syndrome" in vascular access for hemodialysis]. G Chir (1997) 0.75
Recurrent pulmonary embolism with second-degree atrioventricular block and near syncope. Am Heart J (1993) 0.75
Ulnar innervation of the thenar eminence with preservation of median innervation of first lumbrical muscle. Muscle Nerve (1997) 0.75
In vitro effect of clozapine on hemopoietic progenitor cells. Haematologica (1998) 0.75
Parenteral lipid emulsion-induced atherosclerosis in the obese Zucker rat and its lean littermate. Artery (1992) 0.75
A simple vascular access for hemodialysis in "desperate" cases. Ital J Surg Sci (1986) 0.75
Posttransplant renal monitoring with B-flow ultrasonography. Transplant Proc (2010) 0.75
The effect of atherogenic infusions of the triglyceride-rich, lipid emulsion, Lipofundin-S, on the in vitro growth characteristics of rat aortic smooth muscle cells. Artery (1992) 0.75
Low-rate nerve stimulation during regional ischemia in the diagnosis of muscle glycogenosis. Muscle Nerve (1996) 0.75
Morphofunctional features of human extrinsic ocular muscles. Doc Ophthalmol (1989) 0.75
Cardiogenic shock due to huge right atrial thrombus. Chest (1993) 0.75